What are the Home Infusion Therapy Market Key Insights and COVID-19 Business Impact?

Home infusion therapy market will witness to have a positive impact with the pandemic in 2020. Rising geriatric population across the globe is predicted to be the major driving factor for the market in the estimated period. Moreover, increasing prevalence of chronic diseases is predicted to drive the market in the estimated period. Presence of complicated reimbursement policies is predicted to be the biggest restraint for the market in the estimated time frame. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global market.

According to a study conducted by Research Dive, the global home infusion therapy market is expected to register a revenue of $49.5 billion till 2027, growing at a rate of 11.7% CAGR during, 2020-2027. The global market is classified on the basis of product and application. The report provides detailed information about drivers, opportunities, restraints, segmental analysis and competitive players of the market.

Download Exclusive FREE Sample Copy of the Report https://www.researchdive.com/download-sample/360

Factors Affecting the Market Growth

As per our analyst, rise in the geriatric population among the population across the region is predicted to be the major driving factor for the market in the forecast period. Moreover, Presence of complicated reimbursement policies is predicted to be the biggest restraint for the market in the estimated time frame.

Infusion Pumps Segment is predicted have the Highest Growth Rate

On the basis of product, the global home infusion therapy market is further classified into needleless connectors, intravenous sets, infusion pumps and IV cannulas. Infusion Pumps is predicted to grow with a CAGR of 11.8% by generating a revenue of $25.4 billion by 2027. Increasing adoption of infusion pump for treating geriatric population and rising demand for syringe is predicted to boost the segment market in the estimated period.

Anti-Infective is predicted to Have Highest Market Share

On the basis of application, the global home infusion therapy market is further classified into anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals and others. Anti-Infective segment is predicted to grow with a CAGR of 12.5% by generating a revenue of $12.1 billion by 2027.Increasing adoption of anti-fungal and antibiotic drug reduces the exposer to patient with other hospital acquired infection is predicted to drive the market in the forecast period.

Regional Breakdown of the Market

On the basis of region, the global home infusion therapy market is further classified into North America, Europe, Asia-Pacific and LAMEA. North America region is predicted to grow with a CAGR of 11.5% by generating a revenue of $17.1 billion by 2027. Increasing adoption of new technology and rise development of alternate healthcare setting is predicted to boost the region market in the estimated timeframe.

Top 10 Prominent Players in the Home Infusion Therapy Market are:

1. Cosmed
2. Terumo Corporation
3. Smiths Medical.
4. JMS Co., Ltd.
5. ICU Medical Inc.
6. Fresenius Kabi
7. Eli Lilly and Company
8. Becton, Dickinson and Company (BD)
9. Baxter International, Inc.
10. B Braun Melsungen AG

Reference: https://www.researchdive.com/press-release/home-infusion-therapy-market.html

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

COVID-19 Impact: Which Are the Key Players Evolving In the Growth of Assisted Reproductive Technology Market?

The worldwide spread of COVID-19 has positively impacted the global assisted reproductive technology market . This is mainly due to supportive government policies and the strategic steps taken by major market players in the pandemic crisis. For instance, in June 2020, SART launched its fertility expert’s podcast series. Furthermore, the global market is expected to observe substantial growth even after the pandemic owing to the growing adoption of R&D and growing awareness amongst people regarding assisted reproductive technology. The global assisted reproductive technology market is likely to experience an increase in the growth rate during the COVID-19 pandemic. As per a new report added by Research Dive, the global assisted reproductive technology market is anticipated to reach up to $56.3 billion during the forecast period from 2019 to 2026. Comprehensive analysis on drivers, challenges, growth opportunities, major segments, and key strategies executed by maj...

Why Dynamics of Organ Care System Market for Liver Is Changing Drastically? What If History Is Any Guide?

The COVID-19 outbreak has helped the global organ care system market to grow at a positive rate. The manufactures of the industry are investing more in R&D activities to grow exponentially during the forecast period. The COVID-19 pandemic has positively impacted the global Organ care system (OCS) for liver market and a slight increase in the growth rate is observed from the previous predictions. As per new Research Dive published report, the global OCS for liver market is anticipated to grow at a CAGR of 9.3% by 2026, generating a revenue of $42.7 million in the period of forecast from 2019 to 2026. To better understand the pandemic effect on the global market, the report includes comprehensive analysis on growth opportunities, restraints, drivers, vital segments, and strategies adopted by major market players. For More Detail Insights, Download FREE Sample at: https://www.researchdive.com/download-sample/253 Highlights of the Report As per our analysts, the risi...

COVID-19 Impact: What Challenges Medical Tourism Market May See In Next 5 Years?

The COVID-19 crisis has affected the global medical tourism market in a negative way. The governments are taking initiatives to help patients seek healthcare treatment and the market is likely to recover by Q1/Q2 of 2022. The COVID-19 pandemic has hugely impacted the global medical tourism market and a slight downfall is witnessed in the growth rate as compared to the former predictions. As per new Research Dive published report, the global medical tourism market is anticipated to rise at a CAGR of 11.7% by 2026, generating a revenue of $142.2 billion in the period of forecast from 2019 to 2026. While there is a decrease in the growth rate due to the COVID-19 outbreak, the market is likely to recover by Q1/Q2 of 2022. For More Detail Insights, Download FREE Sample at : https://www.researchdive.com/download-sample/248 Highlights of the Report As per our analysts, the increasing interests amongst people coupled with technological advancements in healthcare treatment is...

MyTrade-Insights

Search This Blog